Ronald van Rij, theme Infectious diseases and global health, has been appointed Professor of Experimental Virology at Radboud University / Radboud university medical center with effect from 1 July 2019.Ronald van Rij has been working at Radboudumc since 2008, where he conducts research into viruses transmitted by mosquitoes, such as the Dengue and Zika viruses. His research group mainly studies the molecular interplay between virus, human host and mosquito.
Ronald van Rij (1972, Hellevoetsluis) received his Master’s in Bioprocess Technology at Wageningen University in 1996 and from 1997-2002 worked as a researcher at Sanquin Research (previously the Central Laboratory of the Netherlands Red Cross Blood Transfusion Service) in Amsterdam. In 2002 he obtained his PhD (cum laude) at the University of Amsterdam on research into Chemokine receptors in HIV-1 infection and AIDS pathogenesis.
He then worked for four years as a postdoctoral researcher at the University of California San Francisco (USA). Back in the Netherlands, he became a researcher at the Hubrecht Institute for Developmental Biology and Stem Cell Research. In 2008 Van Rij came to Radboud university medical center and the Radboud Institute for Molecular Life Sciences (RIMLS), where he set up a new research group with the help of a Hypatia Tenure Track Grant, a Radboudumc programme in which excellent researchers develop to become leaders within their academic fields.
Since 2012, he has been head of the Experimental Virology Laboratory of the Medical Microbiology Department. In 2018 he was a visiting professor at the University of Pavia (Italy). In addition to his research, Van Rij provides virology, innate immunity and RNA biology education in various BSc and MSc programmes.
Van Rij received a large number of grants and scholarships for his work, including an ERC Consolidator Grant (2013) and a grant from the Human Frontiers Science Program (2017) for research into the antiviral immune system of mosquitoes that contain the Dengue and Zika viruses transfer. The antiviral immune system of the mosquito is a critical determining factor for the transmission of viruses. His VICI Grant (2017) is intended for research into the role of small RNAs in gene regulation and mosquito antiviral defences.
Related news items
Radboud-led collaboration generates innovative candidate drug against malaria19 September 2019
A molecule once designed to cure the skin disease psoriasis appears to be particularly effective against malaria. The antimalarial properties were revealed thanks to one researcher’s inspired hunch when the psoriasis drug discovery programme came to a dead end.read more
Radboud university medical center opens first healthcare AI labs19 September 2019
These are the first two ‘labs’ in the east of the Netherlands that are part of the national Innovation Center for Artificial Intelligence and the first health labs. With these two initiatives, Radboudumc and its partners are investing heavily in the application of AI to health care.read more
Careful prescription of addictive painkillers still necessary19 September 2019
Although the use of opioid painkillers in the Netherlands has risen over the past ten years, it is nowhere near the degree to which they are used in the United States, say Arnt Schellekens and his colleagues in an article published in The Lancet Public Health.read more
Exercising at home has a positive effect on Parkinson's patients19 September 2019
In a large double-blind study, Radboudumc researchers show that patients in the early stages of Parkinson's disease can exercise regularly at home for 6 months.read more
A personal touch of Kartika Hapsari18 September 2019
In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t. This week: Kartika Hapsari.read more